跳至主要内容
临床试验/NL-OMON31488
NL-OMON31488已完成不适用

Effects of the norepinephrine reuptake inhibitor reboxetine on the exploitation-exploration trade-off - Norepinephrine and exploitation/exploration

Centre for Human Drug Research0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy volunteers between 18 and 25 years of age.
  • Volunteers are willing to give written informed consent to participate in the study and to comply with the study procedures.
  • Participants should speak Dutch fluently.
  • Normal or corrected-to-normal vision.

排除标准

  • Clinically significant abnormal values for clinical chemistry, haematology or urinalysis at screening.
  • Clinically significant abnormal physical examination, vital signs or 12-lead ECG at screening.
  • Clinically significant (history of) psychiatric illness.
  • Clinically significant (history of) major internal or neurological illness.
  • Use of psychotropic medication.
  • Alcohol or substance abuse.
  • Pregnancy or breast feeding.
  • Positive urine screen for drugs of abuse.
  • Clinically significant acute illness within 7 days prior to study drug administration.
  • Clinically significant history of food and/or drug allergies.
  • Serology positive for hepatitis B surface antigen, hepatitis C antibodies or HIV antibodies.
  • Have received an experimental drug or used an experimental medical device within 90 days before the planned start of treatment.
  • Psychological and/or emotional problems which would render the informed consent invalid, or limit the ability of the subject to comply with the study requirements.
  • Donation of 1 or more units (approximately 450 ml) of blood or acute blood loss of an equivalent amount of blood within 90 days before the planned treatment.
  • Exposure to any medication, including over-the-counter medication (not including paracetamol), within 2 weeks prior to treatment.
  • Subject not able to refrain from alcohol from 10 PM the night prior to the experimental session until end of the study day.
  • Subject not able to refrain from smoking from 10 PM the night prior to the experimental session until end of the study day.
  • Subject not able to refrain from xanthine intake from 10 PM the night prior to the experimental session until end of the study day.
  • Subject not able to refrain from grapefruit intake from 14 days prior to the experimental session until end of the study day.
  • Subject not able to refrain from heavy physical exertion from 24 hours prior to the experimental session until end of the study day.

研究者

相似试验